Financials Urteste S.A.

Equities

URT

PLURTST00010

Biotechnology & Medical Research

Market Closed - Warsaw S.E. 09:25:55 17/05/2024 pm IST 5-day change 1st Jan Change
94 PLN 0.00% Intraday chart for Urteste S.A. -1.05% -13.76%

Valuation

Fiscal Period: December 2021
Capitalization 1 109.4
Enterprise Value (EV) 1 100.8
P/E ratio -47.1 x
Yield -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -43.8 x
EV / FCF -4,37,18,878 x
FCF Yield -0%
Price to Book 11.3 x
Nbr of stocks (in thousands) 1,140
Reference price 2 95.90
Announcement Date 18/03/22
1PLN in Million2PLN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021
Net sales - -
EBITDA 1 -1.207 -2.301
EBIT 1 -1.222 -2.321
Operating Margin - -
Earnings before Tax (EBT) 1 -1.221 -2.322
Net income 1 -1.221 -2.322
Net margin - -
EPS - -2.036
Free Cash Flow - -2.306
FCF margin - -
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - -
Dividend per Share - -
Announcement Date 18/03/22 18/03/22
1PLN in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021
Net Debt 1 - -
Net Cash position 1 0.43 8.53
Leverage (Debt/EBITDA) - -
Free Cash Flow - -2.31
ROE (net income / shareholders' equity) - -44.8%
ROA (Net income/ Total Assets) - -27.3%
Assets 1 - 8.507
Book Value Per Share - 8.500
Cash Flow per Share - 7.480
Capex 1 0.04 0.66
Capex / Sales - -
Announcement Date 18/03/22 18/03/22
1PLN in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. URT Stock
  4. Financials Urteste S.A.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW